However, although upregulation of BNIP-3 is associated with good survival outcome in invasive breast carcinoma, it is also linked to an increased risk of recurrence and shorter disease-free survival in DCIS (71). This evidence concerns the gene BNIP3 and invasive breast carcinoma.